Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications

Open access
Shim, Raymond, Wong, Connie·2016·International Journal of Molecular Sciences

Abstract

The incidence of stroke has risen over the past decade and will continue to be one of the leading causes of death and disability worldwide. While a large portion of immediate death following stroke is due to cerebral infarction and neurological complications, the most common medical complication in stroke patients is infection. In fact, infections, such as pneumonia and urinary tract infections, greatly worsen the clinical outcome of stroke patients. Recent evidence suggests that the disrupted interplay between the central nervous system and immune system contributes to the development of infection after stroke. The suppression of systemic immunity by the nervous system is thought to protect the brain from further inflammatory insult, yet this comes at the cost of increased susceptibility to infection after stroke. To improve patient outcome, there have been attempts to lessen the stroke-associated bacterial burden through the prophylactic use of broad-spectrum antibiotics. However, preventative antibiotic treatments have been unsuccessful, and therefore have been discouraged. Additionally, with the ever-rising obstacle of antibiotic-resistance, future therapeutic options to reverse immune impairment after stroke by augmentation of host immunity may be a viable alternative option. However, cautionary steps are required to ensure that collateral ischemic damage caused by cerebral inflammation remains minimal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17010064

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 113

  1. Ann, H. (2004). The Atlas of Heart Disease and Stroke, World Heath Organisation. Chapter 16.
  2. Strong, 2007, Preventing stroke: Saving lives around the world, Lancet Neurol., 6, 182, 10.1016/S1474-4422(07)70031-5 · DOI · Paper page
  3. Cadilhac, 2009, Estimating the long-term costs of ischemic and hemorrhagic stroke for australia: New evidence derived from the north east melbourne stroke incidence study (NEMESIS), Stroke, 40, 915, 10.1161/STROKEAHA.108.526905 · DOI
  4. Mozaffarian, 2015, Heart disease and stroke statistics—2015 update: A report from the American Heart Association, Circulation, 131, e29
  5. Chu, 2007, Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation, Stroke, 38, 177, 10.1161/01.STR.0000252091.36912.65 · DOI · Paper page
  6. Sims, 2010, Mitochondria, oxidative metabolism and cell death in stroke, Biochim. Biophys. Acta BBA Mol. Basis Dis., 1802, 80, 10.1016/j.bbadis.2009.09.003 · DOI · Paper page
  7. Bohacek, 2012, Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury, J. Neuroinflamm., 9, 2094, 10.1186/1742-2094-9-191 · DOI
  8. Sansing, 2011, Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage, Ann. Neurol., 70, 646, 10.1002/ana.22528 · DOI · Paper page
  9. Yilmaz, 2010, Leukocyte recruitment and ischemic brain injury, Neuromol. Med., 12, 193, 10.1007/s12017-009-8074-1 · DOI · Paper page
  10. Gertz, 2012, Essential role of interleukin-6 in post-stroke angiogenesis, Brain, 135, 1964, 10.1093/brain/aws075 · DOI · Paper page
  11. Pradillo, 2012, Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats, J. Cereb. Blood Flow Metab., 32, 1810, 10.1038/jcbfm.2012.101 · DOI
  12. Lenglet, 2014, Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice, J. Cereb. Blood Flow Metab., 34, 802, 10.1038/jcbfm.2014.9 · DOI
  13. Ruscher, 2013, Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke, J. Cereb. Blood Flow Metab., 33, 1225, 10.1038/jcbfm.2013.71 · DOI
  14. Liesz, 2011, Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke, Brain, 134, 704, 10.1093/brain/awr008 · DOI · Paper page
  15. Abramov, 2007, Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation, J. Neurosci., 27, 1129, 10.1523/JNEUROSCI.4468-06.2007 · DOI · Paper page
  16. Heuschmann, 2004, Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German Stroke Registers Study Group, Arch. Intern. Med., 164, 1761, 10.1001/archinte.164.16.1761 · DOI · Paper page
  17. Vahedi, 2007, Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials, Lancet Neurol., 6, 215, 10.1016/S1474-4422(07)70036-4 · DOI · Paper page
  18. Kleinschnitz, 2003, In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging, J. Cereb. Blood Flow Metab., 23, 1356, 10.1097/01.WCB.0000090505.76664.DB · DOI
  19. Clausen, B.H., Lambertsen, K.L., Babcock, A.A., Holm, T.H., Dagnaes-Hansen, F., and Finsen, B. (2008). Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflamm., 5. · DOI · Paper page
  20. Gregersen, 2000, Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice, J. Cereb. Blood Flow Metab., 20, 53, 10.1097/00004647-200001000-00009 · DOI · Paper page
  21. Hu, 2012, Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia, Stroke, 43, 3063, 10.1161/STROKEAHA.112.659656 · DOI · Paper page
  22. Buck, 2008, Early neutrophilia is associated with volume of ischemic tissue in acute stroke, Stroke, 39, 355, 10.1161/STROKEAHA.107.490128 · DOI · Paper page
  23. Li, 2012, Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules, Neurochem. Int., 60, 458, 10.1016/j.neuint.2012.01.026 · DOI
  24. Morrison, 2011, Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion, Biol. Res. Nurs., 13, 154, 10.1177/1099800410384500 · DOI
  25. Price, 2004, Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: An imaging-based study, Stroke, 35, 1659, 10.1161/01.STR.0000130592.71028.92 · DOI · Paper page
  26. Harris, A.K., Ergul, A., Kozak, A., Machado, L.S., Johnson, M.H., and Fagan, S.C. (2005). Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci., 6. · DOI
  27. Cuartero, 2013, N2 neutrophils, novel players in brain inflammation after stroke modulation by the PPARγ agonist rosiglitazone, Stroke, 44, 3498, 10.1161/STROKEAHA.113.002470 · DOI · Paper page
  28. Hurn, 2007, T-and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation, J. Cereb. Blood Flow Metab., 27, 1798, 10.1038/sj.jcbfm.9600482 · DOI · Paper page
  29. Kleinschnitz, 2010, Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation, Blood, 115, 3835, 10.1182/blood-2009-10-249078 · DOI · Paper page
  30. Offner, 2012, A novel hypothesis: Regulatory B lymphocytes shape outcome from experimental stroke, Transl. Stroke Res., 3, 324, 10.1007/s12975-012-0187-4 · DOI
  31. Ren, 2011, Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke, J. Neurosci., 31, 8556, 10.1523/JNEUROSCI.1623-11.2011 · DOI · Paper page
  32. Jin, 2010, Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells, J. Leukoc. Biol., 87, 779, 10.1189/jlb.1109766 · DOI · Paper page
  33. Liesz, 2009, Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke, Nat. Med., 15, 192, 10.1038/nm.1927 · DOI · Paper page
  34. Kleinschnitz, 2013, Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature, Blood, 121, 679, 10.1182/blood-2012-04-426734 · DOI · Paper page
  35. Fu, 2015, Immune interventions in stroke, Nat. Rev. Neurol., 11, 524, 10.1038/nrneurol.2015.144 · DOI · Paper page
  36. Langhauser, 2014, Blocking of α4 integrin does not protect from acute ischemic stroke in mice, Stroke, 45, 1799, 10.1161/STROKEAHA.114.005000 · DOI
  37. Dirnagl, 2014, Are we ready to translate T-cell transmigration in stroke?, Stroke, 45, 1610, 10.1161/STROKEAHA.114.005294 · DOI
  38. Schwab, 2005, Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients, Science, 309, 1735, 10.1126/science.1113640 · DOI · Paper page
  39. Wei, 2011, Fingolimod provides long-term protection in rodent models of cerebral ischemia, Ann. Neurol., 69, 119, 10.1002/ana.22186 · DOI · Paper page
  40. Campos, 2013, Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model, Stroke, 44, 505, 10.1161/STROKEAHA.112.679043 · DOI
  41. Fu, 2014, Impact of an immune modulator fingolimod on acute ischemic stroke, Proc. Natl. Acad. Sci. USA, 111, 18315, 10.1073/pnas.1416166111 · DOI · Paper page
  42. Liu, 2012, Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood–brain barrier damage in early ischemic stroke stage, J. Neurosci., 32, 3044, 10.1523/JNEUROSCI.6409-11.2012 · DOI · Paper page
  43. Amaro, 2015, Relevance of blood–brain barrier disruption after endovascular treatment of ischemic stroke dual-energy computed tomographic study, Stroke, 46, 673, 10.1161/STROKEAHA.114.008147 · DOI
  44. Becker, 2011, Autoimmune responses to the brain after stroke are associated with worse outcome, Stroke, 42, 2763, 10.1161/STROKEAHA.111.619593 · DOI
  45. Gan, 2014, Ischemic neurons recruit natural killer cells that accelerate brain infarction, Proc. Natl. Acad. Sci. USA, 111, 2704, 10.1073/pnas.1315943111 · DOI · Paper page
  46. Planas, 2012, Brain-derived antigens in lymphoid tissue of patients with acute stroke, J. Immunol., 188, 2156, 10.4049/jimmunol.1102289 · DOI · Paper page
  47. Langhorne, 2000, Medical complications after stroke a multicenter study, Stroke, 31, 1223, 10.1161/01.STR.31.6.1223 · DOI · Paper page
  48. Vernino, 2003, Cause-specific mortality after first cerebral infarction a population-based study, Stroke, 34, 1828, 10.1161/01.STR.0000080534.98416.A0 · DOI · Paper page
  49. Corrado, 2006, Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: A 5-year follow-up study, Stroke, 37, 482, 10.1161/01.STR.0000198813.56398.14 · DOI
  50. Kimura, 2005, Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack, Cerebrovasc. Dis., 19, 171, 10.1159/000083252 · DOI
  51. Ulm, 2012, Impact of infections on long-term outcome after severe middle cerebral artery infarction, J. Neurol. Sci., 319, 15, 10.1016/j.jns.2012.05.042 · DOI
  52. Wilson, 2012, Mortality and cost of pneumonia after stroke for different risk groups, J. Stroke Cerebrovasc. Dis., 21, 61, 10.1016/j.jstrokecerebrovasdis.2010.05.002 · DOI · Paper page
  53. Smith, C.J., Emsley, H.C., Gavin, C.M., Georgiou, R.F., Vail, A., Barberan, E.M., del Zoppo, G.J., Hallenbeck, J.M., Rothwell, N.J., and Hopkins, S.J. (2004). Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol., 4. · DOI · Paper page
  54. Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock, P., Wardlaw, J., Dennis, M., and Sudlow, C. (2009). Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin-6. PLoS Med., 8. · DOI · Paper page
  55. Wong, 2007, The time course and determinants of temperature within the first 48 h after ischaemic stroke, Cerebrovasc. Dis., 24, 104, 10.1159/000103124 · doi:10.1159/000103124
  56. Patel, M., and Kulendran, A. (2015). Management of Post-Stroke Complications, Springer.
  57. Esayag, 2010, Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia, Am. J. Med., 123, 88. e1, 10.1016/j.amjmed.2009.09.012 · DOI
  58. Hetze, 2013, Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: A bed to bench approach, J. Cereb. Blood Flow Metab., 33, 846, 10.1038/jcbfm.2013.6 · DOI
  59. Walter, 2007, Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit, J. Neurol., 254, 1323, 10.1007/s00415-007-0520-0 · DOI · Paper page
  60. Harms, 2013, Predicting post-stroke pneumonia: The pantheris score, Acta Neurol. Scand., 128, 178, 10.1111/ane.12095 · doi:10.1111/ane.12095
  61. Haeusler, 2008, Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans, Cerebrovasc. Dis., 25, 50, 10.1159/000111499 · DOI · Paper page
  62. Meisel, 2012, Predicting post-stroke infections and outcome with blood-based immune and stress markers, Cerebrovasc. Dis., 33, 580, 10.1159/000338080 · DOI
  63. Vogelgesang, 2008, Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke, Stroke, 39, 237, 10.1161/STROKEAHA.107.493635 · DOI · Paper page
  64. Chapman, 2009, A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke, J. Cereb. Blood Flow Metab., 29, 1764, 10.1038/jcbfm.2009.113 · DOI
  65. Engel, 2015, Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke, J. Neurosci., 35, 7777, 10.1523/JNEUROSCI.1532-14.2015 · DOI
  66. Mantovani, 2011, Neutrophils in the activation and regulation of innate and adaptive immunity, Nat. Rev. Immunol., 11, 519, 10.1038/nri3024 · DOI · Paper page
  67. Seki, 2010, Suppressed neutrophil respiratory burst in patients with haemorrhagic stroke, J. Clin. Neurosci., 17, 187, 10.1016/j.jocn.2009.04.020 · doi:10.1016/j.jocn.2009.04.020
  68. Ruhnau, 2014, Stroke alters respiratory burst in neutrophils and monocytes, Stroke, 45, 794, 10.1161/STROKEAHA.113.003342 · doi:10.1161/strokeaha.113.003342
  69. Offner, 2006, Experimental stroke induces massive, rapid activation of the peripheral immune system, J. Cereb. Blood Flow Metab., 26, 654, 10.1038/sj.jcbfm.9600217 · DOI · Paper page
  70. Vogelgesang, 2014, Immunological consequences of ischemic stroke, Acta Neurol. Scand., 129, 1, 10.1111/ane.12165 · DOI
  71. Haeusler, 2012, Immune responses after acute ischemic stroke or myocardial infarction, Int. J. Cardiol., 155, 372, 10.1016/j.ijcard.2010.10.053 · DOI
  72. Hug, 2011, Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia, Stroke, 42, 3580, 10.1161/STROKEAHA.111.620948 · doi:10.1161/strokeaha.111.620948
  73. Prass, 2003, Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1–like immunostimulation, J. Exp. Med., 198, 725, 10.1084/jem.20021098 · DOI · Paper page
  74. Offner, 2006, Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages, J. Immunol., 176, 6523, 10.4049/jimmunol.176.11.6523 · DOI · Paper page
  75. Theodorou, 2008, T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke, Clin. Exp. Immunol., 152, 456, 10.1111/j.1365-2249.2008.03650.x · DOI
  76. Chamorro, 2005, The early systemic prophylaxis of infection after stroke study a randomized clinical trial, Stroke, 36, 1495, 10.1161/01.STR.0000170644.15504.49 · DOI · Paper page
  77. Engelbertsen, 2013, T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke, Arterioscler. Thromb. Vasc. Biol., 33, 637, 10.1161/ATVBAHA.112.300871 · DOI
  78. Klehmet, 2009, Stroke-induced immunodepression and post-stroke infections: Lessons from the preventive antibacterial therapy in stroke trial, Neuroscience, 158, 1184, 10.1016/j.neuroscience.2008.07.044 · DOI · Paper page
  79. Chamorro, 2006, Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke, J. Neurol. Neurosurg. Psychiatry, 77, 1279, 10.1136/jnnp.2006.100800 · DOI
  80. Emsley, 2003, An early and sustained peripheral inflammatory response in acute ischaemic stroke: Relationships with infection and atherosclerosis, J. Neuroimmunol., 139, 93, 10.1016/S0165-5728(03)00134-6 · DOI · Paper page
  81. Haddad, 2002, Cytokines and neuro–immune–endocrine interactions: A role for the hypothalamic–pituitary–adrenal revolving axis, J. Neuroimmunol., 133, 1, 10.1016/S0165-5728(02)00357-0 · DOI · Paper page
  82. Anne, 2007, Neurohormonal activation in ischemic stroke: Effects of acute phase disturbances on long-term mortality, Curr. Neurovasc. Res., 4, 170, 10.2174/156720207781387169 · doi:10.2174/156720207781387169
  83. Brambilla, 2013, The effect of stroke on immune function, Mol. Cell. Neurosci., 53, 26, 10.1016/j.mcn.2012.08.011 · DOI
  84. Vogelgesang, A., May, V.E., Grunwald, U., Bakkeboe, M., Langner, S., Wallaschofski, H., Kessler, C., Bröker, B.M., and Dressel, A. (2010). Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS ONE, 5. · DOI
  85. Wong, 2011, Functional innervation of hepatic iNKT cells is immunosuppressive following stroke, Science, 334, 101, 10.1126/science.1210301 · DOI · Paper page
  86. Mracsko, 2014, Differential effects of sympathetic nervous system and hypothalamic–pituitary–adrenal axis on systemic immune cells after severe experimental stroke, Brain, Behav. Immun., 41, 200, 10.1016/j.bbi.2014.05.015 · DOI · Paper page
  87. Yeh, 2011, Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit, J. Neurol. Sci., 306, 38, 10.1016/j.jns.2011.04.001 · DOI
  88. Ersoz, 2007, Urinary tract infection and bacteriurua in stroke patients: Frequencies, pathogen microorganisms, and risk factors, Am. J. Phys. Med. Rehabil., 86, 734, 10.1097/PHM.0b013e31813e5f96 · DOI
  89. Teramoto, 2009, Novel preventive and therapeutic strategy for post-stroke pneumonia, Expert Rev. Neurother., 9, 1187, 10.1586/ern.09.72 · DOI
  90. Arai, 2003, Serum substance P concentrations and silent aspiration in elderly patients with stroke, Neurology, 61, 1625, 10.1212/01.WNL.0000096395.80826.23 · doi:10.1212/01.wnl.0000096395.80826.23
  91. Kumar, 2010, Medical complications after stroke, Lancet Neurol., 9, 105, 10.1016/S1474-4422(09)70266-2 · DOI · Paper page
  92. Prass, 2006, Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia, Stroke, 37, 2607, 10.1161/01.STR.0000240409.68739.2b · DOI · Paper page
  93. Dziewas, 2004, Pneumonia in acute stroke patients fed by nasogastric tube, J. Neurol. Neurosurg. Psychiatry, 75, 852, 10.1136/jnnp.2003.019075 · DOI · Paper page
  94. Vargas, 2006, Clinical consequences of infection in patients with acute stroke is it prime time for further antibiotic trials?, Stroke, 37, 461, 10.1161/01.STR.0000199138.73365.b3 · DOI
  95. Harms, H., Prass, K., Meisel, C., Klehmet, J., Rogge, W., Drenckhahn, C., Göhler, J., Bereswill, S., Göbel, U., and Wernecke, K.D. (2008). Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial. PLoS ONE, 3. · DOI · Paper page
  96. Yan, 2015, Etiologic diagnosis and clinical treatment of multiple drug-resistant bacteria infection in elderly patients with stroke-associated pneumonia after neurosurgery, Cell Biochem. Biophys., 71, 731, 10.1007/s12013-014-0256-2 · DOI
  97. Laban, 2015, Nosocomial infections after aneurysmal subarachnoid hemorrhage: Time course and causative pathogens, Int. J. Stroke, 10, 763, 10.1111/ijs.12494 · doi:10.1111/ijs.12494
  98. Westendorp, W.F., Nederkoorn, P.J., Vermeij, J.D., Dijkgraaf, M.G., and van de Beek, D. (2011). Post-stroke infection: A systematic review and meta-analysis. BMC Neurol., 11. · DOI · Paper page
  99. Urra, X., Miró, F., Chamorro, A., and Planas, A.M. (2014). Antigen-specific immune reactions to ischemic stroke. Front. Cell. Neurosci., 8. · DOI
  100. Becker, 2012, Autoimmune responses to brain following stroke, Transl.Stroke Res., 3, 310, 10.1007/s12975-012-0154-0 · DOI
  101. Becker, 2005, Sensitization to brain antigens after stroke is augmented by lipopolysaccharide, J. Cereb. Blood Flow Metab., 25, 1634, 10.1038/sj.jcbfm.9600160 · DOI
  102. Dénes, Á., Ferenczi, S., and Kovács, K.J. (2011). Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflamm., 8. · DOI · Paper page
  103. Aslanyan, 2004, Pneumonia and urinary tract infection after acute ischaemic stroke: A tertiary analysis of the GAIN international trial, Eur. J. Neurol., 11, 49, 10.1046/j.1468-1331.2003.00749.x · DOI · Paper page
  104. Meisel, 2004, Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke, Stroke, 35, 2, 10.1161/01.STR.0000109041.89959.4C · DOI
  105. Nazarbaghi, 2015, An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: Gender-dependent effect, Acta Neurol. Scand., 131, 45, 10.1111/ane.12296 · DOI
  106. Schwarz, 2008, Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: The Mannheim infection in stroke study (MISS), Stroke, 39, 1220, 10.1161/STROKEAHA.107.499533 · DOI
  107. Westendorp, 2015, The preventive antibiotics in stroke study (PASS): A pragmatic randomised open-label masked endpoint clinical trial, Lancet, 385, 1519, 10.1016/S0140-6736(14)62456-9 · DOI · Paper page
  108. Zhang, 2014, Causes of death among persons who survive an acute ischemic stroke, Curr. Neurol. Neurosci. Rep., 14, 1, 10.1007/s11910-014-0467-3 · DOI
  109. Wijdicks, 2009, Preventive antibiotics for infections in acute stroke: A systematic review and meta-analysis, Arch. Neurol., 66, 1076
  110. Kalra, 2015, Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): A prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial, Lancet, 386, 1835, 10.1016/S0140-6736(15)00126-9 · DOI · Paper page
  111. Dziedzic, 2007, Beta-blockers reduce the risk of early death in ischemic stroke, J. Neurol. Sci., 252, 53, 10.1016/j.jns.2006.10.007 · DOI
  112. Sykora, 2015, β-blockers, pneumonia, and outcome after ischemic stroke evidence from virtual international stroke trials archive, Stroke, 46, 1269, 10.1161/STROKEAHA.114.008260 · DOI
  113. Maier, I.L., Karch, A., Mikolajczyk, R., Bähr, M., and Liman, J. (2015). Effect of Beta-blocker therapy on the risk of infections and death after acute stroke-a historical cohort study. PLoS ONE, 10. · DOI

Metadata

Authors
Shim, R., & Wong, C.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-01-05
Volume
17
Issue
1
Pages
64
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2229811649
Cited by
172
References
15
FWCI
6.68
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications. https://app.cochat.ai/papers/10.3390/ijms17010064
The paper
Shim, R., & Wong, C. (2016). Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17010064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.